Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment

被引:428
|
作者
Verlicchi, P. [1 ]
Al Aukidy, M. [1 ]
Galletti, A. [1 ]
Petrovic, M. [2 ,3 ]
Barcelo, D. [3 ,4 ]
机构
[1] Univ Ferrara, Dept Engn, I-44122 Ferrara, Italy
[2] Catalan Inst Water Res ICRA, Girona, Spain
[3] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
[4] Spanish Council Sci Res CSIC, Inst Environm Assessment & Water Studies IDAEA, Dept Environm Chem, Barcelona, Spain
关键词
Hospital effluents; Urban wastewater; Pharmaceuticals; Mass loads; Contribution; Risk analysis; WASTE-WATER TREATMENT; PERSONAL CARE PRODUCTS; MASS-SPECTROMETRY; TREATMENT PLANTS; THERAPEUTIC CLASSES; ACTIVE COMPOUNDS; SURFACE WATERS; MUNICIPAL; DRUGS; CARBAMAZEPINE;
D O I
10.1016/j.scitotenv.2012.04.055
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A study was conducted in an area in north. Italy, on the effluent of two different sized hospitals and the influent and effluent of the receiving municipal treatment plant of one of the examined hospitals. The aim was to investigate 73 selected pharmaceuticals, belonging to twelve different classes, comparing their occurrence in the effluent directly exiting the hospital with that, mixed with the local urban effluent, at the point of its entry and exit from the treatment plant. Consistent differences were found in the concentrations of some antibiotics, analgesics and lipid regulators in the two wastewaters, confirming that hospital effluents should not be considered as possessing the same pollutant nature as urban wastewater. Furthermore, analysis of percentage contributions of the hospital to the treatment plant influent evidences that hospitals represent one of the main sources of pollutants, in particular antibiotics, receptor antagonists and lipid regulators. Hence, an environmental risk assessment, performed on the effluent from the hospital and the influent and effluent from the treatment plant, revealed a high risk for 9 pharmaceuticals in hospital effluent and for 4 of the 9 substances in the treatment plant influent and effluent, with antibiotics being the most critical compounds in terms of contribution and potential environmental risk for the hospital. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 118
页数:10
相关论文
共 50 条
  • [41] Pharmaceuticals and personal care products in Tunisian hospital wastewater: occurrence and environmental risk
    Nasri, Emna
    de la Vega, Ana Cristina Soler
    Marti, Carlos Barata
    Ben Mansour, Hedi
    Diaz-Cruz, Maria Silvia
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2024, 31 (02) : 2716 - 2731
  • [42] Pharmaceuticals in the Environment: Lessons Learned for Reducing Uncertainties in Environmental Risk Assessment
    Brooks, Bryan W.
    Berninger, Jason P.
    Kristofco, Lauren A.
    Ramirez, Alejandro J.
    Stanley, Jacob K.
    Valenti, Theodore W.
    TOXICOLOGY AND HUMAN ENVIRONMENTS, 2012, 112 : 231 - 258
  • [43] Challenges of Regulatory Environmental Risk Assessment for Human Pharmaceuticals with Focus on Antibiotics
    Wess, R. Arno
    Schmidt, Thomas
    Hoeger, Stefan
    CHIMIA, 2020, 74 (03) : 183 - 191
  • [44] PHOTOTOXICITY OF PHARMACEUTICALS IN AQUATIC ORGANISMS - AN IMPORTANT ELEMENT OF ENVIRONMENTAL RISK ASSESSMENT
    Wawryniuk, Milena
    Nalecz-Jawecki, Grzegorz
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2018, (02): : 10 - 29
  • [45] USE OF ACUTE AND CHRONIC ECOTOXICITY DATA IN ENVIRONMENTAL RISK ASSESSMENT OF PHARMACEUTICALS
    Vestel, Jessica
    Caldwell, Daniel J.
    Constantine, Lisa
    D'Aco, Vincent J.
    Davidson, Todd
    Dolan, David G.
    Millard, Steven P.
    Murray-Smith, Richard
    Parke, Neil J.
    Ryan, Jim J.
    Straub, Juerg Oliver
    Wilson, Peter
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2016, 35 (05) : 1201 - 1212
  • [46] Effective Waiver Strategies for Environmental Risk Assessment of Pharmaceuticals in the European Union
    Crawley, Francis E. H.
    Mayfield, David B.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2023, 42 (01) : 75 - 75
  • [47] COMBINED ENVIRONMENTAL RISK ASSESSMENT FOR THE ANTIVIRAL PHARMACEUTICALS GANCICLOVIR AND VALGANCICLOVIR IN EUROPE
    Straub, Jurg Oliver
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2017, 36 (08) : 2205 - 2216
  • [48] Environmental risk assessment of pharmaceuticals: A proposal with special emphasis on European aspects
    Rombke, Jorg
    Knacker, Thomas
    Teichmann, Hanka
    ACS Symposium Series, 2001, 791 : 304 - 319
  • [49] Occurrence, sources and environmental risk assessment of pharmaceuticals in the Sea of Marmara, Turkey
    Korkmaz, Nagihan E.
    Savun-Hekimoglu, Basak
    Aksu, Abdullah
    Burak, Selmin
    Caglar, Nuray Balkis
    SCIENCE OF THE TOTAL ENVIRONMENT, 2022, 819
  • [50] Exploiting monitoring data in environmental exposure modeling and risk assessment of pharmaceuticals
    Boxall, Alistair B. A.
    Williams, Richard
    Keller, Virginie
    Straub, Jurg Oliver
    Monteiro, Sara
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248